Medicare Coverage For Alzheimer’s Drugs Could Align With Degree Of Plaque Removal, Lilly Says
Executive Summary
Company maintains that the upcoming Medicare national coverage policy for Alzheimer’s drugs should not impose the same access restrictions on drugs with better evidence of effectiveness than others.